{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:49:12Z","timestamp":1789249752133,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1221611"],"award-info":[{"award-number":["1221611"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1240060"],"award-info":[{"award-number":["1240060"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Rheumatoid Arthritis (RA) is an autoimmune disease in which\n                      <jats:italic>HLA-DRB1<\/jats:italic>\n                      alleles encoding the \u201cShared Epitope\u201d (SE), located in the \u03b2-chain of class II HLA-DR molecules, constitute the main genetic risk factor. However, there is scarce information about the role of HLA class I genes (\n                      <jats:italic>HLA-ABC<\/jats:italic>\n                      ) in RA susceptibility. The present work aimed to evaluate the distribution of\n                      <jats:italic>HLA-ABC<\/jats:italic>\n                      allele groups in a cohort of Chilean RA patients and healthy subjects (HS), and to explore the influence of\n                      <jats:italic>HLA-DRB1<\/jats:italic>\n                      SE alleles on this distribution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      135 RA patients and 122 HS were genotyped for\n                      <jats:italic>HLA-ABC<\/jats:italic>\n                      . The most frequent allele groups were\n                      <jats:italic>HLA-A*02<\/jats:italic>\n                      (24.0%),\n                      <jats:italic>HLA-B*39.1<\/jats:italic>\n                      (14.2%), and\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      (24.7%) for RA patients, and\n                      <jats:italic>HLA-A*02<\/jats:italic>\n                      (31.5%),\n                      <jats:italic>HLA-A*24<\/jats:italic>\n                      (12.8%) and\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      (17.7%) for HS. RA patients presented a significantly higher frequency of\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0015) and\n                      <jats:italic>HLA-B*39.1<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037) allele groups compared to HS. After applying the Bonferroni correction, the significant difference remained only for the\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      allele group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015). In a subset of RA patients (n\u2009=\u200960), positive for\n                      <jats:italic>HLA-DRB1<\/jats:italic>\n                      SE alleles, the most frequent\n                      <jats:italic>HLA-ABC<\/jats:italic>\n                      allele groups were\n                      <jats:italic>HLA-A*02<\/jats:italic>\n                      (0\u201333.3%),\n                      <jats:italic>HLA-B*39.1<\/jats:italic>\n                      (0\u201316.7%), and\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      (22.2\u201360.0%), whereas\n                      <jats:italic>HLA-B*39.2<\/jats:italic>\n                      and\n                      <jats:italic>HLA-B*52<\/jats:italic>\n                      were the least frequent ones. Overall,\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      was the most frequent allele group across RA patients carrying\n                      <jats:italic>HLA-DRB1<\/jats:italic>\n                      SE alleles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>HLA-C*07<\/jats:italic>\n                      allele group shows a significantly higher presence in RA patients compared to HS. In contrast, the distribution of most other\n                      <jats:italic>HLA-ABC<\/jats:italic>\n                      allele groups in this cohort displays a similar frequency between RA patients and HS, consistent with data from different populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40659-025-00663-w","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T07:36:27Z","timestamp":1766561787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distribution of HLA-ABC allele groups in a cohort of Chilean rheumatoid arthritis patients and healthy individuals"],"prefix":"10.1186","volume":"59","author":[{"given":"Miqueas","family":"Jaime","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucero","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Varela-Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darly","family":"Montano-Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Boz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Cu\u00e9llar-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaxaira","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-6843","authenticated-orcid":false,"given":"Juan C.","family":"Aguill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361. https:\/\/doi.org\/10.1038\/nature01661.","journal-title":"Nature"},{"key":"663_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04731-0","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021. https:\/\/doi.org\/10.1007\/s00296-020-04731-0.","journal-title":"Rheumatol Int"},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3899\/jrheum.190396","volume":"47","author":"J Dur\u00e1n","year":"2020","unstructured":"Dur\u00e1n J, Massardo L, Llanos C, Iacobelli S, Burgos PI, Cisternas M, et al. The prevalence of rheumatoid arthritis in Chile: a nationwide study performed as part of the national health survey. J Rheumatol. 2020;47:951\u20138. https:\/\/doi.org\/10.3899\/jrheum.190396.","journal-title":"J Rheumatol"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62:1576\u201382. https:\/\/doi.org\/10.1002\/art.27425.","journal-title":"Arthritis Rheum"},{"key":"663_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.10.001","author":"G Zandman-Goddard","year":"2007","unstructured":"Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev. 2007. https:\/\/doi.org\/10.1016\/j.autrev.2006.10.001.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"663_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346. https:\/\/doi.org\/10.1002\/art.21575.","journal-title":"Arthritis Rheum"},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ng.3379","volume":"47","author":"TL Lenz","year":"2015","unstructured":"Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S, et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015;47:1085\u201390. https:\/\/doi.org\/10.1038\/ng.3379.","journal-title":"Nat Genet"},{"key":"663_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1489","author":"R Horton","year":"2004","unstructured":"Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004. https:\/\/doi.org\/10.1038\/nrg1489.","journal-title":"Nat Rev Genet"},{"issue":"30","key":"663_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"1987","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;1987(30):1205\u201313.","journal-title":"Arthritis Rheum."},{"key":"663_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328336ba63","author":"J Holoshitz","year":"2010","unstructured":"Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol. 2010. https:\/\/doi.org\/10.1097\/BOR.0b013e328336ba63.","journal-title":"Curr Opin Rheumatol"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Ronnelid","year":"2005","unstructured":"Ronnelid J, Wick M, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al. Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64:1744\u20139. https:\/\/doi.org\/10.1136\/ard.2004.033571.","journal-title":"Ann Rheum Dis"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/art.24135","volume":"60","author":"B Ding","year":"2009","unstructured":"Ding B, Padyukov L, Lundstr\u00f6m E, Seielstad M, Plenge RM, Oksenberg JR, et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 2009;60:30\u20138. https:\/\/doi.org\/10.1002\/art.24135.","journal-title":"Arthritis Rheum"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, De Jong BAW, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155\u201363. https:\/\/doi.org\/10.1002\/1529-0131(200001)43:1%3c155::AID-ANR20%3e3.0.CO;2-3.","journal-title":"Arthritis Rheum"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/ard.2007.075382","volume":"67","author":"D Mewar","year":"2008","unstructured":"Mewar D, Marinou I, Coote AL, Moore DJ, Akil M, Smillie D, et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Ann Rheum Dis. 2008;67:980\u20133. https:\/\/doi.org\/10.1136\/ard.2007.075382.","journal-title":"Ann Rheum Dis"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1084\/jem.20131241","volume":"210","author":"SW Scally","year":"2013","unstructured":"Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med. 2013;210:2569\u201382. https:\/\/doi.org\/10.1084\/jem.20131241.","journal-title":"J Exp Med"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/art.21385","volume":"52","author":"TWJ Huizinga","year":"2005","unstructured":"Huizinga TWJ, Amos CI, Van Der Helm-Van Mil AHM, Chen W, Van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005;52:3433\u20138. https:\/\/doi.org\/10.1002\/art.21385.","journal-title":"Arthritis Rheum"},{"key":"663_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02431-z","author":"LK Tan","year":"2021","unstructured":"Tan LK, Too CL, Diaz-Gallo LM, Wahinuddin S, Lau IS, Heselynn H, et al. The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study. Arthritis Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13075-021-02431-z.","journal-title":"Arthritis Res Ther"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1002\/art.20608","volume":"50","author":"HS Lee","year":"2004","unstructured":"Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum. 2004;50:3468\u201375. https:\/\/doi.org\/10.1002\/art.20608.","journal-title":"Arthritis Rheum"},{"key":"663_CR19","unstructured":"Liu SC. Influence of HLA-DRB1 Genes and the Shared Epitope on Genetic Susceptibility to Rheumatoid Arthritis in Taiwanese. J Rheumatol. 2007; www.jrheum.org."},{"key":"663_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021069","author":"T Chun-Lai","year":"2011","unstructured":"Chun-Lai T, Padyukov L, Dhaliwal JS, Lundstr\u00f6m E, Yahya A, Muhamad NA, et al. Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)\u2014positive rheumatoid arthritis in three Asian ethnic groups. PLoS ONE. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0021069.","journal-title":"PLoS ONE"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/ard.2009.118018","volume":"69","author":"Y Okada","year":"2010","unstructured":"Okada Y. HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69:1569\u201370. https:\/\/doi.org\/10.1136\/ard.2009.118018.","journal-title":"Ann Rheum Dis"},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biology9120467","volume":"9","author":"P Castro-Santos","year":"2020","unstructured":"Castro-Santos P, Olloquequi J, Verdugo RA, Guti\u00e9rrez MA, Pinochet C, Qui\u00f1ones LA, et al. HLA-DRB1*07:01 and *08:02 alleles confer a protective effect against ACPA-positive rheumatoid arthritis in a latin american admixed population. Biology (Basel). 2020;9:1\u201311. https:\/\/doi.org\/10.3390\/biology9120467.","journal-title":"Biology (Basel)."},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.56.3.191","volume":"56","author":"A Gonzalez","year":"1997","unstructured":"Gonzalez A, Nicovani S, Massardo L, Aguirre V, Cervilla V, Lanchbury JS, et al. Influence of the HLA-DR beta shared epitope on susceptibility to and clinical expression of rheumatoid arthritis in Chilean patients. Ann Rheum Dis. 1997;56:191\u20133.","journal-title":"Ann Rheum Dis."},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110\u20134. https:\/\/doi.org\/10.1038\/nature20810.","journal-title":"Nature"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44:291\u20136. https:\/\/doi.org\/10.1038\/ng.1076.","journal-title":"Nat Genet"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.humimm.2009.08.006","volume":"70","author":"AH Schmidt","year":"2009","unstructured":"Schmidt AH, Baier D, Solloch UV, Stahr A, Cereb N, Wassmuth R, et al. Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning. Hum Immunol. 2009;70:895\u2013902. https:\/\/doi.org\/10.1016\/j.humimm.2009.08.006.","journal-title":"Hum Immunol"},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1399-0039.1996.tb02670.x","volume":"48","author":"RF Schipper","year":"1996","unstructured":"Schipper RF, Schreuder GMT, D\u2019Amaro J, Oudshoorn M, Hla G, Schipper\u2019 RF, et al. Haplotype frequencies in Dutch blood donors. Tissue Antigens. 1996;48:562\u201374. https:\/\/doi.org\/10.1111\/j.1399-0039.1996.tb02670.x.","journal-title":"Tissue Antigens."},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1399-0039.2004.00313.x","volume":"64","author":"K Ayed","year":"2004","unstructured":"Ayed K, Ayed-Jendoubi S, Sfar I, Labonne MP, Gebuhrer L. HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data. Tissue Antigens. 2004;64:520\u201332. https:\/\/doi.org\/10.1111\/j.1399-0039.2004.00313.x.","journal-title":"Tissue Antigens"},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/iji.12064","volume":"41","author":"F Wang","year":"2014","unstructured":"Wang F, He J, Chen S, Qin F, Dai B, Zhang W, et al. HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies in 6384 umbilical cord blood units and transplantation matching and engraftment statistics in the Zhejiang cord blood bank of China. Int J Immunogenet. 2014;41:13\u20139. https:\/\/doi.org\/10.1111\/iji.12064.","journal-title":"Int J Immunogenet"},{"key":"663_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.humimm.2019.03.006","volume":"80","author":"IA P\u00e1ez-Guti\u00e9rrez","year":"2019","unstructured":"P\u00e1ez-Guti\u00e9rrez IA, Hern\u00e1ndez-Mej\u00eda DG, Vanegas D, Camacho-Rodr\u00edguez B, Perdomo-Arciniegas AM. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies of 1463 umbilical cord blood units typed in high resolution from Bogot\u00e1, Colombia. Hum Immunol. 2019;80:425\u20136. https:\/\/doi.org\/10.1016\/j.humimm.2019.03.006.","journal-title":"Hum Immunol."},{"key":"663_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.04.017","author":"C Ravazzi-Gauch","year":"2016","unstructured":"Ravazzi-Gauch C, Bajay MM, Caldas HC, Abbud-Filho M. HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates. Hum Immunol. 2016. https:\/\/doi.org\/10.1016\/j.humimm.2016.04.017.","journal-title":"Hum Immunol."},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.humimm.2016.05.020","volume":"77","author":"C Sch\u00e4fer","year":"2016","unstructured":"Sch\u00e4fer C, Sauter J, Riethm\u00fcller T, Kashi ZM, Schmidt AH, Barriga FJ. HLA-A, -B, -DRB1 allele and haplotype frequencies of 920 cord blood units from Central Chile. Hum Immunol. 2016;77:622\u20133. https:\/\/doi.org\/10.1016\/j.humimm.2016.05.020.","journal-title":"Hum Immunol."},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/tan.13775","volume":"95","author":"P Castro-Santos","year":"2020","unstructured":"Castro-Santos P, Olloquequi J, D\u00edaz-Pe\u00f1a R. HLA-A, B, C and DRB1 alleles in a Chilean population from Talca. HLA. 2020;95:200\u20133. https:\/\/doi.org\/10.1111\/tan.13775.","journal-title":"HLA"},{"key":"663_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1175135","author":"UV Solloch","year":"2023","unstructured":"Solloch UV, Giani AS, Pattillo Garnham MI, Sauter J, Bernas SN, Lange V, et al. HLA allele and haplotype frequencies of registered stem cell donors in Chile. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1175135.","journal-title":"Front Immunol."},{"key":"663_CR35","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/ard.2010.148619","volume":"70","author":"K Britsemmer","year":"2011","unstructured":"Britsemmer K, Ursum J, Gerritsen M, Van Tuyl L, Van Schaardenburg D. Validation of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis. 2011;70:1468\u201370. https:\/\/doi.org\/10.1136\/ard.2010.148619.","journal-title":"Ann Rheum Dis"},{"key":"663_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-020-00284-5","author":"RA Verdugo","year":"2020","unstructured":"Verdugo RA, Di Genova A, Herrera L, Moraga M, Acu\u00f1a M, Berr\u00edos S, et al. Development of a small panel of SNPs to infer ancestry in Chileans that distinguishes Aymara and Mapuche components. Biol Res. 2020. https:\/\/doi.org\/10.1186\/s40659-020-00284-5.","journal-title":"Biol Res."},{"key":"663_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005602","author":"JR Homburger","year":"2015","unstructured":"Homburger JR, Moreno-Estrada A, Gignoux CR, Nelson D, Sanchez E, Ortiz-Tello P, et al. Genomic insights into the ancestry and demographic history of South America. PLoS Genet. 2015. https:\/\/doi.org\/10.1371\/journal.pgen.1005602.","journal-title":"PLoS Genet."},{"key":"663_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004572","author":"A Ruiz-Linares","year":"2014","unstructured":"Ruiz-Linares A, Adhikari K, Acu\u00f1a-Alonzo V, Quinto-Sanchez M, Jaramillo C, Arias W, et al. Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals. PLoS Genet. 2014. https:\/\/doi.org\/10.1371\/journal.pgen.1004572.","journal-title":"PLoS Genet."},{"key":"663_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7472","author":"S Eyheramendy","year":"2015","unstructured":"Eyheramendy S, Martinez FI, Manevy F, Vial C, Repetto GM. Genetic structure characterization of Chileans reflects historical immigration patterns. Nat Commun. 2015. https:\/\/doi.org\/10.1038\/ncomms7472.","journal-title":"Nat Commun."},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4067\/S0716-97602001000300011","volume":"34","author":"J Cuenca","year":"2001","unstructured":"Cuenca J, P\u00e9rez CA, Aguirre AJ, Schiattino I, Aguill\u00f3n JC. Genetic polymorphism at position \u2212308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res. 2001;34:237\u201341. https:\/\/doi.org\/10.4067\/S0716-97602001000300011.","journal-title":"Biol Res"},{"key":"663_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/rheumatology\/keg092","volume":"42","author":"J Cuenca","year":"2003","unstructured":"Cuenca J, Cuchacovich M, P\u00e9rez C, Ferreira L, Aquirre A, Schiattino I, et al. The - 308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology. 2003;42:308\u201313. https:\/\/doi.org\/10.1093\/rheumatology\/keg092.","journal-title":"Rheumatology"},{"key":"663_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/art.1780350306","volume":"35","author":"A Gonz\u00e1lez","year":"1992","unstructured":"Gonz\u00e1lez A, Nicovani S, Massardo L, Bull P, Rodr\u00edguez L, Jacobelli S. Novel genetic markers of rheumatoid arthritis in chilean patients, by dr serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum. 1992;35:282\u20139. https:\/\/doi.org\/10.1002\/art.1780350306.","journal-title":"Arthritis Rheum"},{"key":"663_CR43","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s11033-013-2509-3","volume":"40","author":"D Rey","year":"2013","unstructured":"Rey D, Parga-Lozano C, Moscoso J, Areces C, Enriquez-De-Salamanca M, Fern\u00e1ndez-Honrado M, et al. HLA genetic profile of Mapuche (Araucanian) Amerindians from Chile. Mol Biol Rep. 2013;40:4257\u201367. https:\/\/doi.org\/10.1007\/s11033-013-2509-3.","journal-title":"Mol Biol Rep"},{"key":"663_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01821-x","author":"A Ben Bnina","year":"2024","unstructured":"Ben Bnina A, Yessine A, El Bahri Y, Chouchene S, Ben Lazrek N, Mimouna M, et al. Contribution of HLA class I (A, B, C) and HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes in exploring ethnic origin of central Tunisians. BMC Med Genomics. 2024. https:\/\/doi.org\/10.1186\/s12920-024-01821-x.","journal-title":"BMC Med Genomics"},{"key":"663_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ajhg.2014.02.013","volume":"94","author":"B Han","year":"2014","unstructured":"Han B, Diogo D, Eyre S, Kallberg H, Zhernakova A, Bowes J, et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet. 2014;94:522\u201332. https:\/\/doi.org\/10.1016\/j.ajhg.2014.02.013.","journal-title":"Am J Hum Genet"},{"key":"663_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","volume":"78","author":"JD Reveille","year":"2019","unstructured":"Reveille JD, Zhou X, Lee MJ, Weisman MH, Yi L, Gensler LS, et al. HLA class I and II alleles in susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2019;78:66\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213779.","journal-title":"Ann Rheum Dis"},{"key":"663_CR47","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ng.3379","volume":"47","author":"TL Lenz","year":"2015","unstructured":"Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S, et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015;47:1085\u201390. https:\/\/doi.org\/10.1038\/ng.3379.","journal-title":"Nat Genet"},{"key":"663_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.147","author":"D McGonagle","year":"2015","unstructured":"McGonagle D, Aydin SZ, G\u00fcl A, Mahr A, Direskeneli H. \u2019MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease. Nat Rev Rheumatol. 2015. https:\/\/doi.org\/10.1038\/nrrheum.2015.147.","journal-title":"Nat Rev Rheumatol"},{"key":"663_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.143","author":"CA Dendrou","year":"2018","unstructured":"Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018. https:\/\/doi.org\/10.1038\/nri.2017.143.","journal-title":"Nat Rev Immunol"},{"key":"663_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1594723","author":"D Catal\u00e1n","year":"2025","unstructured":"Catal\u00e1n D, Soto L, Neira \u00d3, Cu\u00e9llar-Guti\u00e9rrez MC, D\u00edaz-Pe\u00f1a R, Aravena O, et al. HLA-DRB1 allele distribution in Chilean population: insights into rheumatoid arthritis susceptibility and protection. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1594723.","journal-title":"Front Immunol"},{"key":"663_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.23","author":"Y Kochi","year":"2010","unstructured":"Kochi Y, Suzuki A, Yamada R, Yamamoto K. Ethnogenetic heterogeneity of rheumatoid arthritisimplications for pathogenesis. Nat Rev Rheumatol. 2010. https:\/\/doi.org\/10.1038\/nrrheum.2010.23.","journal-title":"Nat Rev Rheumatol"},{"key":"663_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11767","author":"D Lagutkin","year":"2024","unstructured":"Lagutkin D, Panaifo L, Nurul-Aain AF, Israelsson L, Hansson M, Lundberg K, et al. Revisiting the link between HLA-DRB1 alleles and autoantibodies in rheumatoid arthritis: association of non-shared epitope alleles *09 and *15 with high levels of anti-citrullinated peptide\/protein antibodies. ACR Open Rheumatol. 2024. https:\/\/doi.org\/10.1002\/acr2.11767.","journal-title":"ACR Open Rheumatol."},{"key":"663_CR53","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/art.38376","volume":"66","author":"B Menon","year":"2014","unstructured":"Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, et al. Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 2014;66:1272\u201381. https:\/\/doi.org\/10.1002\/art.38376.","journal-title":"Arthritis Rheumatol"},{"key":"663_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.38941","volume":"67","author":"H Carvalheiro","year":"2015","unstructured":"Carvalheiro H, Duarte C, Silva-Cardoso S, Da Silva JAP, Souto-Carneiro MM. CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity. Arthritis Rheumatol. 2015;67:363\u201371. https:\/\/doi.org\/10.1002\/art.38941.","journal-title":"Arthritis Rheumatol"},{"key":"663_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.74","author":"A Petrelli","year":"2016","unstructured":"Petrelli A, Van Wijk F. CD8+ T cells in human autoimmune arthritis: the unusual suspects. Nat Rev Rheumatol. 2016. https:\/\/doi.org\/10.1038\/nrrheum.2016.74.","journal-title":"Nat Rev Rheumatol"},{"key":"663_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35264-8","author":"JS Moon","year":"2023","unstructured":"Moon JS, Younis S, Ramadoss NS, Iyer R, Sheth K, Sharpe O, et al. Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-022-35264-8.","journal-title":"Nat Commun"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-025-00663-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:03:07Z","timestamp":1768834987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40659-025-00663-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1186\/s40659-025-00663-w","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants signed a written informed consent in accordance with the Declaration of Helsinki. The Ethics Committees of HCUCH and HDS approved all procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}